Home
Clinical Resources Search
PQI: Epcoritamab (Epkinly) for Relapsed/Refractory Diffuse Large B-Cell Lymphoma and Follicular Lymphoma

Epcoritamab (Epkinly) for Relapsed/Refractory Diffuse Large B-Cell Lymphoma and Follicular Lymphoma

Download PQI pdf

Last Updated: May 5, 2026

By: Syed Zia Khan, PharmD, BCSCP

About this PQI

The purpose of this PQI is to discuss clinical considerations of epcoritamab (Epkinly®) treatment for patients with relapsed/refractory (R/R) diffuse large B-cell lymphoma (DLBCL) and follicular lymphoma (FL).

How to Use a Positive Quality Intervention (PQI)

Essentially, it’s a tool to improve patient care by sharing best practices in oncology care.

Consider this standardized, peer-review clinical guidance to oncology healthcare teams, enabling you and your team to consistently deliver high-quality care to your patients.

Frequently Searched

Supported by

Epcoritamab (Epkinly) for Relapsed/Refractory Diffuse Large B-Cell Lymphoma and Follicular Lymphoma

About this PQI

How to Use a Positive Quality Intervention (PQI)

Find Similar Resources

PQI: Ruxolitinib Extended Release for the Management of Myelofibrosis, Polycythemia Vera, and Graft-Versus-Host Disease

PQI: Gedatolisib Combination Therapy for Locally Advanced or Metastatic Breast Cancer

PQI: Cardiovascular Risk associated with Androgen Deprivation Therapy (ADT) in Prostate Cancer

PQI: Relacorilant (LIFYORLI) and Albumin-Bound Paclitaxel (Nab-Paclitaxel) for Platinum-Resistant Ovarian Cancer

PQI in Action: Inavolisib (Itovebi) Patient Management

PQI in Action: Revumenib (Revuforj) for the Management of Acute Leukemia

PQI in Action: Capivasertib (Truqap) Patient Management

PQI in Action: Sutimlimab-jome (Enjaymo) for the Management of Hemolysis in Cold Agglutinin Disease (CAD)

Treatment Support Kit: Elranatamab

Treatment Support Kit: Bispecific (T-Cell Engager)

Treatment Support Kit: Zanidatamab-hrii

Treatment Support Kit: Avutometinib and Defactinib

Up Close with Axicabtagene Ciloleucel

Up Close with Lisocabtagene Maraleucel

Up Close with Tisagenlecleucel

PQI: Tafasitamab-cxix (Monjuvi) for Relapsed/Refractory Follicular Lymphoma

Up Close with Axicabtagene Ciloleucel

Up Close with Lisocabtagene Maraleucel

Up Close with Tisagenlecleucel

Comparison of CAR-T Cell Therapies

Epcoritamab and R2

Epcoritamab and GemOx

PQI in Action: Epcoritamab (Epkinly) for Relapsed/Refractory Diffuse Large B-Cell Lymphoma and Follicular Lymphoma

Bispecific T-Cell Engagers in Non-Hodgkin Lymphoma: Treatment Discussion Guide

PQI: Ruxolitinib Extended Release for the Management of Myelofibrosis, Polycythemia Vera, and Graft-Versus-Host Disease

S11 E9: Keep Saying Yes: Living, Advocating, and Finding Purpose with Cancer

Rusfertide (Mimrylo)

Lirafugratinib (Lyrfigtu)